Mission, Vision & Strategy


We are resolved in our commitment to provide hope and relief to patients and their families by developing innovative, groundbreaking drugs in the fields of Alzheimer’s disease, pain and other severe diseases.


Our vision is to become a leading neuroscientific research and development company that creates great value for patients and society.


AlzeCure Pharma’s strategy is to develop a broad portfolio of symptomatic, disease-modifying and preventive drugs for Alzheimer’s, pain and other severe illnesses through work based on the following four guidelines:

  • The right patient: Focusing on genetically, clinically and pathologically defined diseases to increase the ability of clinical effect
  • The right mechanism: The treatment acts on genetically associated signaling pathways in Alzheimer’s disease and other indications.
  • The right clinical testing: The clinical studies are based on validated biomarkers and preclinical methods with good translationto humans.
  • The right treatment: Small-molecule drugs that penetrate the blood brain barrier (BBB) and which are designed for safe, efficacious long-term treatment.